🇸🇬 KANJINTI in Singapore

KANJINTI (TRASTUZUMAB-ANNS) regulatory status in Singapore.

Marketing authorisation

HSA

  • Status: likely_approved

KANJINTI in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in Singapore

Frequently asked questions

Is KANJINTI approved in Singapore?

Yes. HSA has authorised it.

Who is the marketing authorisation holder for KANJINTI in Singapore?

AMGEN INC is the originator. The local marketing authorisation holder may differ — check the official source linked above.